| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3688
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37247 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16Z99-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0031 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16Z99-00 |
| filingDate |
2010-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_281390beb6f74a8f1ea93bd40d005cdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2aad0030972dbb49807108c6df6945c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccad79e28966b503a8b58601df53fcc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acf32bce7892fad4ce93897173d995f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c6ebd5389736e0a00de2e99f2f77ec1 |
| publicationDate |
2011-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011196450-A1 |
| titleOfInvention |
Electronic prescription activation device |
| abstract |
This disclosure describes techniques for configuring an IMD into the exposure operating mode. Prior to a medical procedure that generates a disruptive energy field, such as an MRI scan, an electronic prescription is configured to indicate that the IMD is authorized for the medical procedure that includes a disruptive energy field. The electronic prescription includes one or more designated bits within a storage element of the IMD. When the patient in which the IMD is implanted arrives for the medical procedure, a user (such as an MRI operator) interacts with a telemetry device to determine whether the electronic prescription is configured. Upon determining that the electronic prescription is configured, the IMD transitions into the exposure operating mode designed for operation in the disruptive energy field. In this manner, the electronic prescription confirms to the user that that the IMD has been checked for suitability for operation during the medical procedure. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013053920-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022168578-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9827417-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9272152-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446148-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9675806-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9586043-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021298903-A1 |
| priorityDate |
2010-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |